Ingredion (INGR) shares plummeted 5.44% in Tuesday's pre-market trading session following the release of disappointing third-quarter 2025 financial results and a downward revision to its full-year sales forecast. The ingredient solutions provider's performance fell short of analyst expectations, sparking concerns among investors.

For the third quarter, Ingredion reported adjusted earnings per share (EPS) of $2.75, missing the IBES estimate of $2.92 and marking a 9.84% decrease from $3.05 per share in the same period last year. The company's Q3 sales also disappointed, reaching $1,816 million against an expected $1,903 million, representing a 2.89% year-over-year decline. This underperformance in both earnings and revenue likely contributed to the negative market reaction.

Adding to investor concerns, Ingredion updated its outlook for the full year 2025. The company now expects net sales to be "flat to down low single-digits," a downward revision from previous guidance. Despite the sales pressure, Ingredion maintained its full-year adjusted EPS forecast in the range of $11.10 to $11.30, narrowing it from the previous $11.10 to $11.60. The company also provided its capital expenditure outlook for the fiscal year, projecting CAPEX between $400 million and $425 million. These adjustments suggest that Ingredion is facing challenges in its market environment, potentially due to reduced consumer demand and ongoing production issues in some of its key segments.